Evidence map›Paper›PMID 33485775›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2021

Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients.

Danielle Sganga, Seth A Hollander, Sumeet Vaikunth, Christiane Haeffele, Rachel Bensen, Manchula Navaratnam, Nancy McDonald, Elizabeth Profita, Katsuhide Maeda, Waldo Concepcion and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Fontan-Associated Liver Disease.Seminars in liver disease · 2025
    Review
  11. Review
  12. Article
  13. The majority of pediatric Fontan patients have excellent post-transplant survival.The Journal of thoracic and cardiovascular surgery · 2024
    Article
  14. Contemporary Management of the Failing Fontan.Journal of clinical medicine · 2024
    Review
  15. Rejection in the setting of combined Heart and Liver Transplantation.International journal of cardiology. Congenital heart disease · 2024
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Danielle SgangaDepartments of Pediatrics. Electronic address: dsganga@stanford.edu.
Seth A HollanderDepartments of Pediatrics.
Sumeet VaikunthDepartments of Pediatrics.
Christiane HaeffeleDepartment of Medicine.
Rachel BensenDepartments of Pediatrics.
Manchula NavaratnamDepartment of Anesthesia, Stanford University, Palo Alto, California.
Nancy McDonaldDivision of Pediatric Cardiology, Lucile Packard Children's Hospital, Palo Alto, California.
Elizabeth ProfitaDepartments of Pediatrics.
Katsuhide MaedaDepartment of Cardiothoracic Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvannia.
Waldo ConcepcionDepartment of Transplantation Services, Mohammed Bin Rashid University School of Medicine, Dubai, UAE.
Daniel BernsteinDepartments of Pediatrics.
Sharon ChenDepartments of Pediatrics.
Children's Hospital of Philadelphia · USLucile Packard Children's Hospital · USMohammed Bin Rashid University of Medicine and Health Sciences · AEPalo Alto University · US

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
NCATS NIH HHS UL1 TR001085NCATS NIH HHS UL1 TR003142
6 · The paper itself

Abstract

backgroundIndications for a heart‒liver transplantation (HLT) for Fontan recipients are not well defined. We compared listing characteristics, post-operative complications, and post-transplant outcomes of Fontan recipients who underwent HLT with those of patients who underwent heart-only transplantation (HT). We hypothesized that patients who underwent HLT have increased post-operative complications but superior survival outcomes compared with patients who underwent HT.

methodsWe performed a retrospective review of Fontan recipients who underwent HLT or HT at a single institution. Characteristics at the time of listing, including the extent of liver disease determined by laboratory, imaging, and biopsy data, were compared. Post-operative complications were assessed, and the Kaplan‒Meier survival method was used to compare post-transplant survival. Univariate regression analyses were performed to identify the risk factors for increased mortality and morbidity among patients who underwent HT.

resultsA total of 47 patients (9 for HLT, 38 for HT) were included. Patients who underwent HLT were older, were more likely to be on dual inotrope therapy, and had evidence of worse liver disease. Whereas ischemic time was longer for the group who underwent HLT, post-operative complications were similar. Over a median post-transplant follow-up of 17 (interquartile range: 5-52) months, overall mortality for the cohort was 17%; only 1 patient who underwent HLT died (11%) vs 7 patients who underwent HT (18%) (p = 0.64). Among patients who underwent HT, cirrhosis on pre-transplant imaging was associated with worse outcomes.

conclusionsDespite greater inotrope need and more severe liver disease at the time of listing, Fontan recipients undergoing HLT have post-transplant outcomes comparable with those of patients undergoing HT. HLT may offer a survival benefit for Fontan recipients with liver disease.

Indexed as

Fontan ProcedureAdolescentCaliforniaChildFemaleFollow-Up StudiesGraft SurvivalHeart Defects, CongenitalHeart TransplantationHumansIncidenceLiver TransplantationMalePostoperative ComplicationsPrognosisRetrospective StudiesFontanheart failureheart‒liver transplantationpediatric heart transplantationsingle ventricle

Identifiers

PMID33485775
PMCPMC8026537
OpenAlexW3116169288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.